$NERV Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Minerva Neurosciences, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Minerva Neurosciences, Inc.. Get notifications about new insider transactions in Minerva Neurosciences, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 15 2021 | NERV | Minerva Neuroscien ... | DOYLE WILLIAM F | Director | Option Exercise | A | 2.90 | 40,000 | 116,000 | 40,000 | |
Jun 15 2021 | NERV | Minerva Neuroscien ... | VAN HEEK G JAN | Director | Option Exercise | A | 2.90 | 20,000 | 58,000 | 20,000 | |
Dec 16 2020 | NERV | Minerva Neuroscien ... | Reilly Joseph H. | SVP & Chief Operati ... | Option Exercise | M | 0.00 | 8,750 | 0 | 0 | |
Dec 16 2020 | NERV | Minerva Neuroscien ... | Reilly Joseph H. | SVP & Chief Operati ... | Sell | S | 2.64 | 3,228 | 8,522 | 31,747 | 35 K to 31.7 K (-9.23 %) |
Dec 16 2020 | NERV | Minerva Neuroscien ... | Reilly Joseph H. | SVP & Chief Operati ... | Buy | M | 0.00 | 8,750 | 0 | 34,975 | 26.2 K to 35 K (+33.37 %) |
Dec 16 2020 | NERV | Minerva Neuroscien ... | Race Geoff | EVP, CFO & CBO | Option Exercise | M | 0.00 | 12,500 | 0 | 0 | |
Dec 16 2020 | NERV | Minerva Neuroscien ... | Race Geoff | EVP, CFO & CBO | Sell | S | 2.64 | 6,190 | 16,342 | 211,354 | 217.5 K to 211.4 K (-2.85 %) |
Dec 16 2020 | NERV | Minerva Neuroscien ... | Race Geoff | EVP, CFO & CBO | Buy | M | 0.00 | 12,500 | 0 | 217,544 | 205 K to 217.5 K (+6.10 %) |
Dec 16 2020 | NERV | Minerva Neuroscien ... | Luthringer Remy | CEO | Option Exercise | M | 0.00 | 18,750 | 0 | 0 | |
Dec 16 2020 | NERV | Minerva Neuroscien ... | Luthringer Remy | CEO | Sell | S | 2.64 | 1,300 | 3,432 | 66,490 | 67.8 K to 66.5 K (-1.92 %) |
Dec 16 2020 | NERV | Minerva Neuroscien ... | Luthringer Remy | CEO | Buy | M | 0.00 | 18,750 | 0 | 67,790 | 49 K to 67.8 K (+38.23 %) |
Dec 16 2020 | NERV | Minerva Neuroscien ... | Ahlholm Frederick W | SVP, Chief Accounti ... | Option Exercise | M | 0.00 | 5,000 | 0 | 0 | |
Dec 16 2020 | NERV | Minerva Neuroscien ... | Ahlholm Frederick W | SVP, Chief Accounti ... | Sell | S | 2.64 | 1,845 | 4,871 | 10,039 | 11.9 K to 10 K (-15.53 %) |
Dec 16 2020 | NERV | Minerva Neuroscien ... | Ahlholm Frederick W | SVP, Chief Accounti ... | Buy | M | 0.00 | 5,000 | 0 | 11,884 | 6.9 K to 11.9 K (+72.63 %) |
Oct 14 2020 | NERV | Minerva Neuroscien ... | Smith Devin Whittemore | SVP and General Cou ... | Option Exercise | A | 3.50 | 85,000 | 297,500 | 85,000 | |
Oct 14 2020 | NERV | Minerva Neuroscien ... | Race Geoff | EVP, CFO & CBO | Option Exercise | A | 3.50 | 140,000 | 490,000 | 140,000 | |
Oct 14 2020 | NERV | Minerva Neuroscien ... | Luthringer Remy | CEO | Option Exercise | A | 3.50 | 200,000 | 700,000 | 200,000 | |
Oct 14 2020 | NERV | Minerva Neuroscien ... | Davidson Michael | Chief Medical Offic ... | Option Exercise | A | 3.50 | 85,000 | 297,500 | 85,000 | |
Oct 14 2020 | NERV | Minerva Neuroscien ... | Reilly Joseph H. | SVP & Chief Operati ... | Option Exercise | A | 3.50 | 85,000 | 297,500 | 85,000 | |
Oct 14 2020 | NERV | Minerva Neuroscien ... | Ahlholm Frederick W | SVP, Chief Accounti ... | Option Exercise | A | 3.50 | 85,000 | 297,500 | 85,000 | |
Oct 14 2020 | NERV | Minerva Neuroscien ... | Saoud Jay | SVP and Head of R&D | Option Exercise | A | 3.50 | 100,000 | 350,000 | 100,000 | |
Sep 11 2020 | NERV | Minerva Neuroscien ... | VAN HEEK G JAN | Director | Buy | P | 2.97 | 7,000 | 20,790 | 20,333 | 13.3 K to 20.3 K (+52.50 %) |
Aug 17 2020 | NERV | Minerva Neuroscien ... | Smith Devin Whittemore | SVP and General Cou ... | Option Exercise | A | 7.11 | 153,531 | 1,091,605 | 153,531 | |
Aug 17 2020 | NERV | Minerva Neuroscien ... | Saoud Jay | SVP and Head of R&D | Option Exercise | A | 7.11 | 236,202 | 1,679,396 | 236,202 | |
Aug 17 2020 | NERV | Minerva Neuroscien ... | Russell Richard E. | President | Option Exercise | A | 7.11 | 185,025 | 1,315,528 | 185,025 | |
Aug 17 2020 | NERV | Minerva Neuroscien ... | Race Geoff | EVP, CFO & CBO | Option Exercise | A | 7.11 | 275,568 | 1,959,288 | 275,568 | |
Aug 17 2020 | NERV | Minerva Neuroscien ... | Luthringer Remy | CEO | Option Exercise | A | 7.11 | 354,302 | 2,519,087 | 354,302 | |
Aug 17 2020 | NERV | Minerva Neuroscien ... | Davidson Michael | Chief Medical Offic ... | Option Exercise | A | 7.11 | 137,784 | 979,644 | 137,784 | |
Jun 12 2020 | NERV | Minerva Neuroscien ... | HILLEMAN JERYL L | Director | Option Exercise | A | 3.40 | 20,000 | 68,000 | 20,000 | |
Jun 12 2020 | NERV | Minerva Neuroscien ... | VAN HEEK G JAN | Director | Option Exercise | A | 3.40 | 20,000 | 68,000 | 20,000 | |
Jun 12 2020 | NERV | Minerva Neuroscien ... | Laghrissi-Thode Fouzia | Director | Option Exercise | A | 3.40 | 20,000 | 68,000 | 20,000 | |
Jun 12 2020 | NERV | Minerva Neuroscien ... | Kupfer David | Director | Option Exercise | A | 3.40 | 20,000 | 68,000 | 20,000 | |
Jun 12 2020 | NERV | Minerva Neuroscien ... | HASLER HANS PETER | Director | Option Exercise | A | 3.40 | 20,000 | 68,000 | 20,000 | |
Jun 12 2020 | NERV | Minerva Neuroscien ... | DOYLE WILLIAM F | Director | Option Exercise | A | 3.40 | 40,000 | 136,000 | 40,000 | |
May 27 2020 | NERV | Minerva Neuroscien ... | Ahlholm Frederick W | SVP, Chief Accounti ... | Sell | S | 15.00 | 8,339 | 125,085 | 6,884 | 15.2 K to 6.9 K (-54.78 %) |
May 27 2020 | NERV | Minerva Neuroscien ... | Ahlholm Frederick W | SVP, Chief Accounti ... | Sell | S | 15.00 | 8,339 | 125,085 | 6,884 | 15.2 K to 6.9 K (-54.78 %) |
Jan 03 2020 | NERV | Minerva Neuroscien ... | Smith Devin Whittemore | SVP and General Cou ... | Option Exercise | A | 7.11 | 41,469 | 294,845 | 41,469 | |
Jan 03 2020 | NERV | Minerva Neuroscien ... | Saoud Jay | SVP and Head of R&D | Option Exercise | A | 7.11 | 63,798 | 453,604 | 63,798 | |
Jan 03 2020 | NERV | Minerva Neuroscien ... | Russell Richard E. | President | Option Exercise | A | 7.11 | 49,975 | 355,322 | 49,975 | |
Jan 03 2020 | NERV | Minerva Neuroscien ... | Reilly Joseph H. | SVP & Chief Operati ... | Option Exercise | A | 7.11 | 41,469 | 294,845 | 41,469 | |
Jan 03 2020 | NERV | Minerva Neuroscien ... | Race Geoff | EVP, CFO & CBO | Option Exercise | A | 7.11 | 74,432 | 529,212 | 74,432 | |
Jan 03 2020 | NERV | Minerva Neuroscien ... | Luthringer Remy | CEO | Option Exercise | A | 7.11 | 95,698 | 680,413 | 95,698 | |
Jan 03 2020 | NERV | Minerva Neuroscien ... | Luthringer Remy | CEO | Option Exercise | A | 7.11 | 95,698 | 680,413 | 95,698 | |
Jan 03 2020 | NERV | Minerva Neuroscien ... | Davidson Michael | Chief Medical Offic ... | Option Exercise | A | 7.11 | 37,216 | 264,606 | 37,216 | |
Jan 03 2020 | NERV | Minerva Neuroscien ... | Davidson Michael | Chief Medical Offic ... | Option Exercise | A | 7.11 | 37,216 | 264,606 | 37,216 | |
Jan 03 2020 | NERV | Minerva Neuroscien ... | Ahlholm Frederick W | SVP, Chief Accounti ... | Option Exercise | A | 7.11 | 37,216 | 264,606 | 37,216 | |
Jan 03 2020 | NERV | Minerva Neuroscien ... | Ahlholm Frederick W | SVP, Chief Accounti ... | Option Exercise | A | 7.11 | 37,216 | 264,606 | 37,216 | |
Dec 17 2019 | NERV | Minerva Neuroscien ... | Race Geoff | EVP, CFO & CBO | Option Exercise | M | 0.00 | 12,500 | 0 | 12,500 | |
Dec 17 2019 | NERV | Minerva Neuroscien ... | Race Geoff | EVP, CFO & CBO | Option Exercise | M | 0.00 | 12,500 | 0 | 12,500 | |
Dec 17 2019 | NERV | Minerva Neuroscien ... | Race Geoff | EVP, CFO & CBO | Sell | S | 7.10 | 5,826 | 41,365 | 205,044 | 210.9 K to 205 K (-2.76 %) |
Dec 17 2019 | NERV | Minerva Neuroscien ... | Race Geoff | EVP, CFO & CBO | Sell | S | 7.10 | 5,826 | 41,365 | 205,044 | 210.9 K to 205 K (-2.76 %) |
Dec 17 2019 | NERV | Minerva Neuroscien ... | Race Geoff | EVP, CFO & CBO | Buy | M | 0.00 | 12,500 | 0 | 210,870 | 198.4 K to 210.9 K (+6.30 %) |
Dec 17 2019 | NERV | Minerva Neuroscien ... | Race Geoff | EVP, CFO & CBO | Buy | M | 0.00 | 12,500 | 0 | 210,870 | 198.4 K to 210.9 K (+6.30 %) |
Dec 17 2019 | NERV | Minerva Neuroscien ... | Luthringer Remy | CEO | Option Exercise | M | 0.00 | 18,750 | 0 | 18,750 | |
Dec 17 2019 | NERV | Minerva Neuroscien ... | Luthringer Remy | CEO | Option Exercise | M | 0.00 | 18,750 | 0 | 18,750 | |
Dec 17 2019 | NERV | Minerva Neuroscien ... | Luthringer Remy | CEO | Sell | S | 7.10 | 2,412 | 17,125 | 49,040 | 51.5 K to 49 K (-4.69 %) |
Dec 17 2019 | NERV | Minerva Neuroscien ... | Luthringer Remy | CEO | Sell | S | 7.10 | 2,412 | 17,125 | 49,040 | 51.5 K to 49 K (-4.69 %) |
Dec 17 2019 | NERV | Minerva Neuroscien ... | Luthringer Remy | CEO | Buy | M | 0.00 | 18,750 | 0 | 51,452 | 32.7 K to 51.5 K (+57.34 %) |
Dec 17 2019 | NERV | Minerva Neuroscien ... | Luthringer Remy | CEO | Buy | M | 0.00 | 18,750 | 0 | 51,452 | 32.7 K to 51.5 K (+57.34 %) |
Dec 17 2019 | NERV | Minerva Neuroscien ... | Ahlholm Frederick W | SVP, Chief Accounti ... | Option Exercise | M | 0.00 | 5,000 | 0 | 5,000 | |
Dec 17 2019 | NERV | Minerva Neuroscien ... | Ahlholm Frederick W | SVP, Chief Accounti ... | Option Exercise | M | 0.00 | 5,000 | 0 | 5,000 | |
Dec 17 2019 | NERV | Minerva Neuroscien ... | Ahlholm Frederick W | SVP, Chief Accounti ... | Sell | S | 7.10 | 1,557 | 11,055 | 15,223 | 16.8 K to 15.2 K (-9.28 %) |
Dec 17 2019 | NERV | Minerva Neuroscien ... | Ahlholm Frederick W | SVP, Chief Accounti ... | Sell | S | 7.10 | 1,557 | 11,055 | 15,223 | 16.8 K to 15.2 K (-9.28 %) |
Dec 17 2019 | NERV | Minerva Neuroscien ... | Ahlholm Frederick W | SVP, Chief Accounti ... | Buy | M | 0.00 | 5,000 | 0 | 16,780 | 11.8 K to 16.8 K (+42.44 %) |
Dec 17 2019 | NERV | Minerva Neuroscien ... | Ahlholm Frederick W | SVP, Chief Accounti ... | Buy | M | 0.00 | 5,000 | 0 | 16,780 | 11.8 K to 16.8 K (+42.44 %) |
Dec 17 2019 | NERV | Minerva Neuroscien ... | Reilly Joseph H. | SVP & Chief Operati ... | Option Exercise | M | 0.00 | 8,750 | 0 | 8,750 | |
Dec 17 2019 | NERV | Minerva Neuroscien ... | Reilly Joseph H. | SVP & Chief Operati ... | Option Exercise | M | 0.00 | 8,750 | 0 | 8,750 | |
Dec 17 2019 | NERV | Minerva Neuroscien ... | Reilly Joseph H. | SVP & Chief Operati ... | Sell | S | 7.10 | 2,724 | 19,340 | 26,225 | 28.9 K to 26.2 K (-9.41 %) |
Dec 17 2019 | NERV | Minerva Neuroscien ... | Reilly Joseph H. | SVP & Chief Operati ... | Sell | S | 7.10 | 2,724 | 19,340 | 26,225 | 28.9 K to 26.2 K (-9.41 %) |
Dec 17 2019 | NERV | Minerva Neuroscien ... | Reilly Joseph H. | SVP & Chief Operati ... | Buy | M | 0.00 | 8,750 | 0 | 28,949 | 20.2 K to 28.9 K (+43.32 %) |
Dec 17 2019 | NERV | Minerva Neuroscien ... | Reilly Joseph H. | SVP & Chief Operati ... | Buy | M | 0.00 | 8,750 | 0 | 28,949 | 20.2 K to 28.9 K (+43.32 %) |
Dec 13 2019 | NERV | Minerva Neuroscien ... | Russell Richard E. | President | Sell | S | 7.42 | 3,113 | 23,098 | 33,770 | 36.9 K to 33.8 K (-8.44 %) |
Jul 01 2019 | NERV | Minerva Neuroscien ... | DOYLE WILLIAM F | Director | Buy | P | 5.50 | 3,500 | 19,250 | 26,111 | 22.6 K to 26.1 K (+15.48 %) |
Jul 01 2019 | NERV | Minerva Neuroscien ... | DOYLE WILLIAM F | Director | Buy | P | 5.50 | 3,500 | 19,250 | 26,111 | 22.6 K to 26.1 K (+15.48 %) |
Jun 27 2019 | NERV | Minerva Neuroscien ... | VAN HEEK G JAN | Director | Buy | P | 5.37 | 10,000 | 53,700 | 13,333 | 3.3 K to 13.3 K (+300.03 %) |
Jun 27 2019 | NERV | Minerva Neuroscien ... | HILLEMAN JERYL L | Director | Buy | P | 5.25 | 1,000 | 5,250 | 1,000 | 0 to 1,000 |
Jun 27 2019 | NERV | Minerva Neuroscien ... | HASLER HANS PETER | Director | Buy | P | 5.60 | 10,000 | 56,000 | 10,000 | 0 to 10 K |
Jun 27 2019 | NERV | Minerva Neuroscien ... | Kupfer David | Director | Buy | P | 5.55 | 10,000 | 55,500 | 219,188 | 209.2 K to 219.2 K (+4.78 %) |
Jun 26 2019 | NERV | Minerva Neuroscien ... | Index Venture Associates III L ... | 10% Owner | Sell | S | 6.01 | 197,000 | 1,184,837 | 3,899,189 | 4.1 M to 3.9 M (-4.81 %) |
Jun 21 2019 | NERV | Minerva Neuroscien ... | Index Venture Associates III L ... | 10% Owner | Sell | S | 4.34 | 33,575 | 145,759 | 4,096,189 | 4.1 M to 4.1 M (-0.81 %) |
Jun 21 2019 | NERV | Minerva Neuroscien ... | Index Venture Associates III L ... | 10% Owner | Sell | S | 4.44 | 77,243 | 343,152 | 4,129,764 | 4.2 M to 4.1 M (-1.84 %) |
Jun 19 2019 | NERV | Minerva Neuroscien ... | Index Venture Associates III L ... | 10% Owner | Sell | S | 4.44 | 49,675 | 220,522 | 4,207,007 | 4.3 M to 4.2 M (-1.17 %) |
Jun 19 2019 | NERV | Minerva Neuroscien ... | Index Venture Associates III L ... | 10% Owner | Sell | S | 4.45 | 56,243 | 250,208 | 4,256,682 | 4.3 M to 4.3 M (-1.30 %) |
Jun 17 2019 | NERV | Minerva Neuroscien ... | Index Venture Associates III L ... | 10% Owner | Sell | S | 4.50 | 25,169 | 113,188 | 4,312,925 | 4.3 M to 4.3 M (-0.58 %) |
Jun 17 2019 | NERV | Minerva Neuroscien ... | Index Venture Associates III L ... | 10% Owner | Sell | S | 4.51 | 53,298 | 240,550 | 4,338,094 | 4.4 M to 4.3 M (-1.21 %) |
Jun 13 2019 | NERV | Minerva Neuroscien ... | Index Venture Associates III L ... | 10% Owner | Sell | S | 4.57 | 26,901 | 122,989 | 4,391,392 | 4.4 M to 4.4 M (-0.61 %) |
Jun 13 2019 | NERV | Minerva Neuroscien ... | Index Venture Associates III L ... | 10% Owner | Sell | S | 4.78 | 33,150 | 158,354 | 4,418,293 | 4.5 M to 4.4 M (-0.74 %) |
Jun 13 2019 | NERV | Minerva Neuroscien ... | DOYLE WILLIAM F | Director | Option Exercise | A | 4.50 | 20,000 | 90,000 | 20,000 | |
May 31 2019 | NERV | Minerva Neuroscien ... | VAN HEEK G JAN | Director | Option Exercise | A | 5.21 | 20,000 | 104,200 | 20,000 | |
May 31 2019 | NERV | Minerva Neuroscien ... | Laghrissi-Thode Fouzia | Director | Option Exercise | A | 5.21 | 20,000 | 104,200 | 20,000 | |
May 31 2019 | NERV | Minerva Neuroscien ... | Kupfer David | Director | Option Exercise | A | 5.21 | 20,000 | 104,200 | 20,000 | |
May 31 2019 | NERV | Minerva Neuroscien ... | HASLER HANS PETER | Director | Option Exercise | A | 5.21 | 20,000 | 104,200 | 20,000 | |
May 31 2019 | NERV | Minerva Neuroscien ... | DOYLE WILLIAM F | Director | Option Exercise | A | 5.21 | 20,000 | 104,200 | 20,000 | |
May 31 2019 | NERV | Minerva Neuroscien ... | HILLEMAN JERYL L | Director | Option Exercise | A | 5.21 | 20,000 | 104,200 | 20,000 | |
May 21 2019 | NERV | Minerva Neuroscien ... | Index Venture Associates III L ... | 10% Owner | Sell | S | 6.08 | 200 | 1,215 | 4,451,443 | 4.5 M to 4.5 M (0.00 %) |
May 21 2019 | NERV | Minerva Neuroscien ... | Index Venture Associates III L ... | 10% Owner | Sell | S | 6.02 | 22,718 | 136,681 | 4,451,643 | 4.5 M to 4.5 M (-0.51 %) |
May 16 2019 | NERV | Minerva Neuroscien ... | Index Venture Associates III L ... | 10% Owner | Sell | S | 6.37 | 44,836 | 285,673 | 4,474,361 | 4.5 M to 4.5 M (-0.99 %) |
May 16 2019 | NERV | Minerva Neuroscien ... | Index Venture Associates III L ... | 10% Owner | Sell | S | 6.64 | 53,418 | 354,466 | 4,519,197 | 4.6 M to 4.5 M (-1.17 %) |
May 16 2019 | NERV | Minerva Neuroscien ... | Index Venture Associates III L ... | 10% Owner | Sell | S | 7.05 | 36,574 | 258,022 | 4,572,615 | 4.6 M to 4.6 M (-0.79 %) |
Dec 26 2018 | NERV | Minerva Neuroscien ... | DOYLE WILLIAM F | Director | Buy | P | 6.50 | 2,000 | 13,000 | 22,611 | 20.6 K to 22.6 K (+9.70 %) |
Dec 26 2018 | NERV | Minerva Neuroscien ... | DOYLE WILLIAM F | Director | Buy | P | 6.50 | 2,000 | 13,000 | 22,611 | 20.6 K to 22.6 K (+9.70 %) |
Dec 18 2018 | NERV | Minerva Neuroscien ... | Race Geoff | EVP, CFO & CBO | Option Exercise | M | 0.00 | 12,500 | 0 | 25,000 | |
Dec 18 2018 | NERV | Minerva Neuroscien ... | Race Geoff | EVP, CFO & CBO | Sell | S | 7.46 | 5,999 | 44,753 | 198,370 | 204.4 K to 198.4 K (-2.94 %) |
Dec 18 2018 | NERV | Minerva Neuroscien ... | Race Geoff | EVP, CFO & CBO | Buy | M | 0.00 | 12,500 | 0 | 204,369 | 191.9 K to 204.4 K (+6.51 %) |
Dec 18 2018 | NERV | Minerva Neuroscien ... | Ahlholm Frederick W | SVP, Chief Accounti ... | Option Exercise | M | 0.00 | 5,000 | 0 | 10,000 | |
Dec 18 2018 | NERV | Minerva Neuroscien ... | Ahlholm Frederick W | SVP, Chief Accounti ... | Sell | S | 7.46 | 1,559 | 11,630 | 11,780 | 13.3 K to 11.8 K (-11.69 %) |
Dec 18 2018 | NERV | Minerva Neuroscien ... | Ahlholm Frederick W | SVP, Chief Accounti ... | Buy | M | 0.00 | 5,000 | 0 | 13,339 | 8.3 K to 13.3 K (+59.96 %) |
Dec 18 2018 | NERV | Minerva Neuroscien ... | Luthringer Remy | CEO | Option Exercise | M | 0.00 | 18,750 | 0 | 37,500 | |
Dec 18 2018 | NERV | Minerva Neuroscien ... | Luthringer Remy | CEO | Sell | S | 7.46 | 2,604 | 19,426 | 32,702 | 35.3 K to 32.7 K (-7.38 %) |
Dec 18 2018 | NERV | Minerva Neuroscien ... | Luthringer Remy | CEO | Buy | M | 0.00 | 18,750 | 0 | 35,306 | 16.6 K to 35.3 K (+113.25 %) |
Dec 18 2018 | NERV | Minerva Neuroscien ... | Reilly Joseph H. | SVP & Chief Operati ... | Option Exercise | M | 0.00 | 8,750 | 0 | 17,500 | |
Dec 18 2018 | NERV | Minerva Neuroscien ... | Reilly Joseph H. | SVP & Chief Operati ... | Sell | S | 7.46 | 2,728 | 20,351 | 20,199 | 22.9 K to 20.2 K (-11.90 %) |
Dec 18 2018 | NERV | Minerva Neuroscien ... | Reilly Joseph H. | SVP & Chief Operati ... | Buy | M | 0.00 | 8,750 | 0 | 22,927 | 14.2 K to 22.9 K (+61.72 %) |
Dec 13 2018 | NERV | Minerva Neuroscien ... | Smith Devin Whittemore | SVP and General Cou ... | Option Exercise | A | 7.96 | 120,000 | 955,200 | 120,000 | |
Dec 13 2018 | NERV | Minerva Neuroscien ... | Saoud Jay | SVP and Head of R&D | Option Exercise | A | 7.96 | 96,000 | 764,160 | 96,000 | |
Dec 13 2018 | NERV | Minerva Neuroscien ... | Russell Richard E. | President | Option Exercise | A | 7.96 | 260,000 | 2,069,600 | 260,000 | |
Dec 13 2018 | NERV | Minerva Neuroscien ... | Russell Richard E. | President | Sell | S | 7.96 | 3,117 | 24,811 | 36,883 | 40 K to 36.9 K (-7.79 %) |
Dec 13 2018 | NERV | Minerva Neuroscien ... | Reilly Joseph H. | SVP & Chief Operati ... | Option Exercise | A | 7.96 | 120,000 | 955,200 | 120,000 | |
Dec 13 2018 | NERV | Minerva Neuroscien ... | Race Geoff | EVP, CFO & CBO | Option Exercise | A | 7.96 | 175,000 | 1,393,000 | 175,000 | |
Dec 13 2018 | NERV | Minerva Neuroscien ... | Luthringer Remy | CEO | Option Exercise | A | 7.96 | 410,000 | 3,263,600 | 410,000 | |
Dec 13 2018 | NERV | Minerva Neuroscien ... | Davidson Michael | Chief Medical Offic ... | Option Exercise | A | 7.96 | 175,000 | 1,393,000 | 175,000 | |
Dec 13 2018 | NERV | Minerva Neuroscien ... | Ahlholm Frederick W | SVP, Chief Accounti ... | Option Exercise | A | 7.96 | 120,000 | 955,200 | 120,000 | |
Dec 12 2018 | NERV | Minerva Neuroscien ... | DOYLE WILLIAM F | Director | Buy | P | 7.95 | 4,000 | 31,800 | 20,611 | 16.6 K to 20.6 K (+24.08 %) |
Dec 12 2018 | NERV | Minerva Neuroscien ... | DOYLE WILLIAM F | Director | Buy | P | 8.00 | 2,000 | 16,000 | 16,611 | 14.6 K to 16.6 K (+13.69 %) |
Nov 21 2018 | NERV | Minerva Neuroscien ... | DOYLE WILLIAM F | Director | Buy | P | 8.20 | 2,000 | 16,400 | 14,611 | 12.6 K to 14.6 K (+15.86 %) |
Oct 15 2018 | NERV | Minerva Neuroscien ... | DOYLE WILLIAM F | Director | Buy | P | 10.00 | 600 | 6,000 | 12,611 | 12 K to 12.6 K (+5.00 %) |
Oct 03 2018 | NERV | Minerva Neuroscien ... | Index Venture Associates III L ... | 10% Owner | Sell | S | 12.35 | 15,444 | 190,747 | 4,609,189 | 4.6 M to 4.6 M (-0.33 %) |
Oct 01 2018 | NERV | Minerva Neuroscien ... | Index Venture Associates III L ... | 10% Owner | Sell | S | 12.62 | 34,589 | 436,344 | 4,624,633 | 4.7 M to 4.6 M (-0.74 %) |
Oct 01 2018 | NERV | Minerva Neuroscien ... | Index Venture Associates III L ... | 10% Owner | Sell | S | 12.57 | 31,684 | 398,274 | 4,659,222 | 4.7 M to 4.7 M (-0.68 %) |
Sep 19 2018 | NERV | Minerva Neuroscien ... | DOYLE WILLIAM F | Director | Buy | P | 10.50 | 1,800 | 18,900 | 12,011 | 10.2 K to 12 K (+17.63 %) |
Sep 19 2018 | NERV | Minerva Neuroscien ... | DOYLE WILLIAM F | Director | Buy | P | 10.50 | 1,800 | 18,900 | 12,011 | 10.2 K to 12 K (+17.63 %) |
Sep 17 2018 | NERV | Minerva Neuroscien ... | DOYLE WILLIAM F | Director | Buy | P | 10.50 | 200 | 2,100 | 10,211 | 10 K to 10.2 K (+2.00 %) |
Sep 17 2018 | NERV | Minerva Neuroscien ... | DOYLE WILLIAM F | Director | Buy | P | 10.50 | 2,000 | 21,000 | 10,011 | 8 K to 10 K (+24.97 %) |
Sep 11 2018 | NERV | Minerva Neuroscien ... | DOYLE WILLIAM F | Director | Buy | P | 9.72 | 4,011 | 38,987 | 8,011 | 4 K to 8 K (+100.28 %) |
Sep 11 2018 | NERV | Minerva Neuroscien ... | DOYLE WILLIAM F | Director | Buy | P | 9.88 | 4,000 | 39,520 | 4,000 | 0 to 4 K |
Aug 24 2018 | NERV | Minerva Neuroscien ... | Reilly Joseph H. | SVP & Chief Operati ... | Option Exercise | M | 4.71 | 25,000 | 117,750 | 42,400 | |
Aug 24 2018 | NERV | Minerva Neuroscien ... | Reilly Joseph H. | SVP & Chief Operati ... | Sell | S | 10.00 | 25,000 | 250,000 | 14,177 | 39.2 K to 14.2 K (-63.81 %) |
Aug 24 2018 | NERV | Minerva Neuroscien ... | Reilly Joseph H. | SVP & Chief Operati ... | Buy | M | 4.71 | 25,000 | 117,750 | 39,177 | 14.2 K to 39.2 K (+176.34 %) |
Aug 02 2018 | NERV | Minerva Neuroscien ... | DOYLE WILLIAM F | Director | Option Exercise | A | 7.95 | 20,000 | 159,000 | 20,000 | |
Aug 02 2018 | NERV | Minerva Neuroscien ... | Smith Devin Whittemore | SVP and General Cou ... | Option Exercise | A | 7.95 | 200,000 | 1,590,000 | 200,000 | |
Jul 17 2018 | NERV | Minerva Neuroscien ... | HILLEMAN JERYL L | Director | Option Exercise | A | 8.20 | 40,000 | 328,000 | 40,000 | |
Jun 11 2018 | NERV | Minerva Neuroscien ... | VAN HEEK G JAN | Director | Option Exercise | A | 8.25 | 20,000 | 165,000 | 20,000 | |
Jun 11 2018 | NERV | Minerva Neuroscien ... | Laghrissi-Thode Fouzia | Director | Option Exercise | A | 8.25 | 20,000 | 165,000 | 20,000 | |
Jun 11 2018 | NERV | Minerva Neuroscien ... | Kupfer David | Director | Option Exercise | A | 8.25 | 20,000 | 165,000 | 20,000 | |
Jun 11 2018 | NERV | Minerva Neuroscien ... | HASLER HANS PETER | Director | Option Exercise | A | 8.25 | 20,000 | 165,000 | 20,000 | |
Jun 11 2018 | NERV | Minerva Neuroscien ... | DOYLE WILLIAM F | Director | Option Exercise | A | 8.25 | 20,000 | 165,000 | 20,000 | |
Feb 02 2018 | NERV | Minerva Neuroscien ... | Beer Marc D | Director | Option Exercise | A | 10.00 | 12,500 | 125,000 | 12,500 | |
Feb 02 2018 | NERV | Minerva Neuroscien ... | Beer Marc D | Director | Option Exercise | D | 10.00 | 12,500 | 125,000 | 0 | |
Feb 02 2018 | NERV | Minerva Neuroscien ... | Beer Marc D | Director | Option Exercise | A | 10.20 | 12,500 | 127,500 | 12,500 | |
Feb 02 2018 | NERV | Minerva Neuroscien ... | Beer Marc D | Director | Option Exercise | D | 10.20 | 12,500 | 127,500 | 0 |